DENTSPLY SIRONA Inc.
NASDAQRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- DENTSPLY SIRONA Inc. DENTSPLY SIRONA Inc. develops, manufactures, and markets a comprehensive portfolio of professional dental products and technologies worldwide, serving dental professionals, laboratories, clinics, and distributors in more than 150 countries. The company, formed by the 2016 merger of DENTSPLY International (founded in 1899 in New York City) and Sirona Dental Systems (founded in 1877 in Erlangen, Germany) and headquartered in Charlotte, North Carolina, offers end-to-end solutions including CAD/CAM systems such as CEREC Primescan, Primemill, and inLab; digital imaging with Orthophos, GALILEOS, and XIOS sensors; treatment centers like Axano, INTEGO, and SINIUS; implants via Astra Tech, Ankylos, and DS OmniTaper systems; consumables encompassing restoratives (SureFil, Celtra Duo, Spectra), endodontics (ProTaper Ultimate, WaveOne Gold, TruNatomy), orthodontics (SureSmile aligners), and infection prevention products; laboratory equipment including CEREC Speedfire furnaces and inFire HTC; handpieces and instruments under the Midwest brand; hygiene systems like DAC Universal; and healthcare consumables through Wellspect such as urological catheters. DENTSPLY SIRONA Inc. operates across key segments including connected technology solutions, essential dental equipment, and consumables, targeting general dentists, specialists, oral surgeons, periodontists, endodontists, and orthodontic practices with a focus on digital dentistry, innovation, and clinical education. In recent strategic developments, the company completed a review of alternatives for its Wellspect Healthcare subsidiary in September 2025 and elected to retain it for enhanced long-term value, amid a multi-year transformation emphasizing operational efficiencies, customer engagement, and portfolio optimization; appointed Aldo M. Denti as Executive Vice President and Chief Commercial Officer in October 2025 to strengthen commercial leadership and align business units; launched innovations like Primescan 2, DS Core platform, Primeprint 3D printing solutions, and enhancements to SureSmile aligners and X-Smart Pro+ endodontic motor; and expanded clinical education through DS World events and DS Academy Campus while advancing sustainability initiatives under the BEYOND program and partnerships like Smile Train.
Company News
DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 1-Year Low – Time to Sell?
Engineers Gate Manager LP Boosts Stake in DENTSPLY SIRONA Inc. $XRAY
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference
Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities
New At-Home Surity™ Urinary Management System Designed to Provide Comfort and Reliable Care for People Living with Urinary Incontinence
Empowered Funds LLC Grows Stake in DENTSPLY SIRONA Inc. $XRAY
DENTSPLY SIRONA Q2 Earnings Call Highlights
XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales
Here's What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earnings
DENTSPLY SIRONA Inc. (XRAY) Q2 2026 Earnings Call Transcript
Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates
Dentsply Sirona Reports Second Quarter 2026 Results
Arkadios Wealth Advisors Purchases New Stake in DENTSPLY SIRONA Inc. $XRAY
DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?
Dimensional Fund Advisors LP Raises Stake in DENTSPLY SIRONA Inc. $XRAY
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship